Richard S Kollender is President and CFO of Strongbridge Biopharma plc. Currently has a direct ownership of 0 shares of SBBP, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2021, when has been sold 234,229 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Richard S Kollender Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2021
SELL
Sale (or disposition) back to the issuer
-
234,229 Reduced 100.0%
0 Ordinary Shares
Oct 01 2021
SELL
Payment of exercise price or tax liability
$133,469 $2.06 p/Share
64,791 Reduced 21.67%
234,229 Ordinary Shares
Sep 03 2021
SELL
Payment of exercise price or tax liability
$38,277 $2.24 p/Share
17,088 Reduced 5.41%
299,020 Ordinary Shares
May 17 2021
SELL
Payment of exercise price or tax liability
$25,974 $2.28 p/Share
11,392 Reduced 3.48%
316,108 Ordinary Shares
Mar 03 2021
BUY
Grant, award, or other acquisition
-
80,000 Added 19.63%
327,500 Ordinary Shares
Jan 07 2021
BUY
Grant, award, or other acquisition
-
147,500 Added 37.34%
247,500 Ordinary Shares

Also insider at

RPID
RAPID MICRO BIOSYSTEMS, INC. Healthcare
RSK

Richard S Kollender

President and CFO
Trevose, PA

Track Institutional and Insider Activities on SBBP

Follow Strongbridge Biopharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBBP shares.

Notify only if

Insider Trading

Get notified when an Strongbridge Biopharma PLC insider buys or sells SBBP shares.

Notify only if

News

Receive news related to Strongbridge Biopharma plc

Track Activities on SBBP